Skip Navigation

European Heart Journal 2003 24(23):2156-2158; doi:10.1016/j.ehj.2003.10.002
Copyright © 2003 by the European Society of Cardiology.
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dieker, H.-J.
Right arrow Articles by Verheugt, F. W.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dieker, H.-J.
Right arrow Articles by Verheugt, F. W.A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Special ESC report

Hotline sessions of the 25th European Congress of Cardiology

Hendrik-Jan Dieker and Freek W.A. Verheugt*

University Medical Centre St. Radboud, Nijmegen, The Netherlands

* Correspondence: Freek W. A. Verheugt, MD, FESC, University Medical Centre St. Radboud, Heartcentre, 540 Cardiology, P.O. Box 9101, Nijmegen, The Netherlands 6500 HB. Tel: +31-24-3614533; Fax: +31-24-3540537
E-mail address: f.verheugt@cardio.umcn.nl

Received 29 September 2003; accepted 3 October 2003

The first 150 words of the full text of this article appear below.

Of the 12 presentations at the two Hotline sessions of the 25th European Congress of Cardiology, held in Vienna, Austria, 30 August–3 September 2003, six are summarized, since the other half of the presentations have been published recently (CHARM studies: Lancet 2003;362:759–781, the EUROPA study: Lancet 2003;362:782–788 and the ESTEEM trial: Lancet 2003;362:789–797). The authors of this summary collected the information given during the presentations of the studies, as well as from press releases prepared by most speakers. This report only shows preliminary results.

During the first Hotline Session, studies on the medical treatment of heart failure were presented. Of the six presented studies, five have already been published.

Dr Christian Mueller from Basel, Switzerland presented the BASEL study. In this open single-centre study patients with acute dyspnoea presenting at the emergency room were randomized to be diagnosed and treated according to standard clinical practice or to standard . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?